Le Lézard
Classified in: Health, Science and technology
Subject: CALENDAR OF EVENTS

Zenith Announces Webcast Presentation at the BIO Investor Forum in San Francisco, CA


Zenith Announces Webcast Presentation at the BIO Investor Forum in San Francisco, CA

CALGARY, Alberta, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (?Zenith? or the ?Company?) today announces its participation in the upcoming BIO Investor Forum in San Francisco, CA. Mr. Donald J. McCaffrey, President and Chief Executive Officer, will provide a corporate update and overview of recent activities at the conference.

Presentation & Webcast Details:

Date: Tuesday, October 17th  
Time: 11:15 am PT
Duration: ~15 minutes
Location: Elizabethan D Room at the Westin St. Francis
Webcast Link:   Click hear to launch the webcast viewer

The presentation will be available on the Company's website immediately prior to the start of the event. Click on this LINK to go directly to the appropriate page on the Company's website. An archived replay of the webcast will also be available on the Company website by clicking on this LINK.

About Zenith

Zenith Capital Corp. is a biotechnology investment company. Zenith Epigenetics Ltd., a wholly-owned subsidiary of Zenith Capital Corp., is a clinical stage biotechnology company focused on the discovery and development of novel therapeutics.  Zenith Epigenetics Ltd.'s bromodomain (BET) inhibitors are being advanced in several oncology indications and have the potential to impact multiple additional diseases as well. The lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (?mCRPC?).

For further information, please contact:                                                          

Clayton Paradis
Zenith Capital Corp.                                                      

Phone: 587-390-7865                            

Email: [email protected]       

Website: www.zenithepigenetics.com


These press releases may also interest you

at 20:25
AHF Praises Colombia for Putting Lives Before Pharma Greed
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC Deputy Registrar, Kathy Lauriente, honoured with Distinguished Service Award from Thompson Rivers University (TRU)
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT Expands to Meet the Growing Need for Self-Harm, Suicidal Thoughts, and Depression Therapy.
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
Notice - NOVA TECH LTD and CYNTHIA PETION, File No. 2023-20
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

More news about Health...


News published on and distributed by: